TABLE 1.
Patient | Age | Diameter (technique) |
Histologic type | Histologic grade |
Proliferative rate |
Receptor overexpression | ||
---|---|---|---|---|---|---|---|---|
ER | PR | HER2 | ||||||
A | 48 | 4.2 cm (US) | IMC-NST | High | High | − | − | − |
B | 46 | NDM | IMC-NST | High | Intermediate | + | + | + |
C | 39 | 10 cm (PE) | ILC | Low | Low | + | + | − |
D | 56 | n/a | IMC-NST | High | Intermediate | + | − | + |
E | 54 | 9 cm (US) | IMC-NST | High | n/a | + | − | − |
F | 64 | 2 cm (US) | IMC-NST | High | n/a | − | − | − |
G | 32 | 2.9 cm (US) | IMC-NST | High | High | + | + | + |
H | 49 | 1.3 cm (US) | IMC-NST | High | Intermediate | − | − | + |
I | 67 | 2.4 cm (US) | IMC-NST | High | High | − | − | − |
J | 39 | 1.9 cm (MRI) | IMC-NST | High | Intermediate | − | − | − |
K | 33 | 4.3 cm (MRI) | IMC-NST | High | High | + | + | − |
L | 44 | 8 cm (PE) | IMC-NST | High | n/a | − | − | − |
M | 57 | 3 cm (US) | IMC-NST | High | High | − | − | − |
N | 43 | 1.8 cm (US) | IMC-NST | High | High | − | − | − |
O | 42 | 1.8 cm (US) | IMC-NST | High | High | − | − | − |
P | 48 | NDM | IMC-NST | High | n/a | − | − | + |
Q | 45 | 3 cm (US) | IMC-NST | High | High | − | + | − |
R | 50 | 2 cm (MRI) | IMC-NST | Intermediate | Intermediate | − | − | − |
S | 55 | 3cm (US) | IMC-NST | Intermediate | Intermediate | + | + | − |
T | 43 | 2.9 cm (MRI) | IMC-NST | High | High | − | − | − |
U | 36 | 1.6 cm | IMC-NST | Intermediate | Low | + | + | − |
V | 65 | 4.6 cm | IMC-NST | Intermediate | Intermediate | − | − | + |
W | 42 | 3.6 cm | IMC-NST | Intermediate | Intermediate | + | + | − |
X | 56 | n/a | IMC-NST | High | High | + | + | − |
ER = estrogen receptor; HER2 = human epidermal growth factor receptor type 2; ILC = invasive lobular carcinoma; IMC-NST = invasive mammary carcinoma, no special type; MRI = magnetic resonance imaging; NDM = no discrete mass; n/a = not available; PE = physical examination; PR = progesterone receptor; US = ultrasound